Said R Beydoun: co-Editor-in-Chief, touchREVIEWS in Neurology
Said R. Beydoun, M.D., FAAN, is co-Editor-in-Chief of touchREVIEWS in Neurology, Professor and Division Chief, Neuromuscular Medicine, at the Department of Neurology at Keck Medicine of USC, University of Southern California. He is Program Director of an ACGME-accredited Clinical Neurophysiology Fellowship, which trains three physicians each year. Dr. Beydoun advocates an integrated approach to clinical diagnosis, diagnostic testing, and treatment options for patients with neuromuscular diseases. As a principal investigator, Dr. Beydoun has participated in multiple research clinical trials. His clinical and research areas of expertise in the field of Neuromuscular Medicine include: Amyotrophic Lateral Sclerosis (ALS), Myasthenia Gravis, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), and TTR Amyloid Neuropathy. He has been published in several scientific journals on topics related to neuromuscular diseases. He is an elected fellow of the American Academy of Neurology and a fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine. He is a member of the medical/scientific advisory board of the Myasthenia Gravis Foundation of America. He is the medical director of the Certified ALS Treatment Center of Excellence at Keck USC. He holds board certification by the American Board of Psychiatry and Neurology in Neurology, Clinical Neurophysiology, Neuromuscular Medicine, and Pain Medicine.
Access more content from Prof. Said Beydoun
Said Beydoun, Rare Disease Day 2022: Understanding myasthenia gravis and the impact on patients’ quality of life
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!